The Clinical Value of Hybrid Sentinel Lymphoscintigraphy to Predict Metastatic Sentinel Lymph Nodes in Breast CancerChang Ju Na, Seok Tae Lim, Jeonghun Kim et al.|Nuclear Medicine and Molecular Imaging|2014Cited by 8
Comparison of Therapeutic Efficacy and Clinical Parameters Between Recombinant Human Thyroid Stimulating Hormone and Thyroid Hormone Withdrawal in High-Dose Radioiodine Treatment with Differentiated Thyroid CancerSehun Choi, Seok Tae Lim, Hee-Kwon Kim et al.|Nuclear Medicine and Molecular Imaging|2014Cited by 5
A phase II clinical trial to investigate the effect of pioglitazone on 18F-FDG uptake in malignant lesionsYeon‐Hee Han, Hwan‐Jeong Jeong, Seong Young Kwon et al.|EJNMMI Research|2015Cited by 4
Comparison of clinical biomarkers and therapeutic efficacy between Rh-TSH and thyroid hormone withdrawal in the first HD-RIT of differentiated thyroid cancerSehun Choi, Myung‐Hee Sohn, Seok Tae Lim et al.|Journal of Nuclear Medicine|2014Cited by 0
Phase II clinical trial to validate usefulness of pioglitazone to differentiate cancerous from inflammatory lesions in patients undergoing FDG PET/CTYeon‐Hee Han, Hwan‐Jeong Jeong, Jeong Hun Kim et al.|Journal of Nuclear Medicine|2014Cited by 0